Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus.

Vieira SM, Monteiro MB, Marques T, Luna AM, Fortes MA, Nery M, Queiroz M, Dib SA, Vendramini MF, Azevedo MJ, Canani LH, Parisi MC, Pavin EJ, Giannella-Neto D, Corrêa-Giannella ML.

BMC Med Genet. 2011 Sep 30;12:129. doi: 10.1186/1471-2350-12-129.

2.

Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.

Patente TA, Mohammedi K, Bellili-Muñoz N, Driss F, Sanchez M, Fumeron F, Roussel R, Hadjadj S, Corrêa-Giannella ML, Marre M, Velho G.

Free Radic Biol Med. 2015 Sep;86:16-24. doi: 10.1016/j.freeradbiomed.2015.04.002. Epub 2015 Apr 8.

PMID:
25862415
3.

Relationship between common functional polymorphisms of the p22phox gene (-930A > G and +242C > T) and nephropathy as a result of Type 2 diabetes in a Chinese population.

Lim SC, Goh SK, Lai YR, Tee WW, Koh A, Xu XH, Wu YS, Yap E, Subramaniam T, Sum CF.

Diabet Med. 2006 Sep;23(9):1037-41.

PMID:
16922713
4.

Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels.

Bekris LM, Shephard C, Janer M, Graham J, McNeney B, Shin J, Zarghami M, Griffith W, Farin F, Kavanagh TJ, Lernmark A.

Exp Clin Endocrinol Diabetes. 2007 Apr;115(4):221-8.

PMID:
17479437
5.

Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes.

Monteiro MB, Patente TA, Mohammedi K, Queiroz MS, Azevedo MJ, Canani LH, Parisi MC, Marre M, Velho G, Corrêa-Giannella ML.

Free Radic Res. 2013 Oct;47(10):804-10. doi: 10.3109/10715762.2013.828347. Epub 2013 Aug 19.

PMID:
23919599
7.

NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure.

Perianayagam MC, Liangos O, Kolyada AY, Wald R, MacKinnon RW, Li L, Rao M, Balakrishnan VS, Bonventre JV, Pereira BJ, Jaber BL.

J Am Soc Nephrol. 2007 Jan;18(1):255-63. Epub 2006 Dec 6.

8.

[Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].

Fanelli A, Hadjadj S, Gallois Y, Fumeron F, Betoule D, Grandchamp B, Marre M.

Arch Mal Coeur Vaiss. 2002 Jul-Aug;95(7-8):701-8. French.

PMID:
12365083
9.
10.

Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals.

Lim SC, Liu JJ, Low HQ, Morgenthaler NG, Li Y, Yeoh LY, Wu YS, Goh SK, Chionh CY, Tan SH, Kon YC, Soon PC, Bee YM, Subramaniam T, Sum CF, Chia KS.

Diabetologia. 2009 Jul;52(7):1343-51. doi: 10.1007/s00125-009-1368-x. Epub 2009 May 5.

PMID:
19415232
11.

Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease.

Hashemi M, Hoseini H, Yaghmaei P, Moazeni-Roodi A, Bahari A, Hashemzehi N, Shafieipour S.

DNA Cell Biol. 2011 Aug;30(8):569-75. doi: 10.1089/dna.2010.1162. Epub 2011 Mar 25.

PMID:
21438662
12.

A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.

Zhang D, Ma J, Brismar K, Efendic S, Gu HF.

J Diabetes Complications. 2009 Jul-Aug;23(4):265-72. doi: 10.1016/j.jdiacomp.2008.05.004. Epub 2008 Jul 3.

PMID:
18599322
13.

Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.

Araki S, Ng DP, Krolewski B, Wyrwicz L, Rogus JJ, Canani L, Makita Y, Haneda M, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2003 Aug;14(8):2015-24.

14.

[The glutamate-cysteine ligase catalytic subunit gene C-129T and modifier subunit gene G-23T polymorphisms and risk for coronary diseases].

Zuo HP, Xu WJ, Luo M, Zhu ZZ, Zhu GS.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Jul;35(7):637-40. Chinese.

PMID:
17961430
15.

Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.

Buraczynska K, Koziol-Montewka M, Majdan M, Tokarz A, Ksiazek A.

Ren Fail. 2004 Nov;26(6):633-9.

PMID:
15600254
16.

Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus.

McKnight AJ, Woodman AM, Parkkonen M, Patterson CC, Savage DA, Forsblom C, Pettigrew KA, Sadlier D, Groop PH, Maxwell AP; Warren 3/UK GoKinD Study Group.

Diabetologia. 2009 May;52(5):844-9. doi: 10.1007/s00125-009-1281-3. Epub 2009 Feb 27.

PMID:
19247629
17.

Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction.

Koide S, Kugiyama K, Sugiyama S, Nakamura S, Fukushima H, Honda O, Yoshimura M, Ogawa H.

J Am Coll Cardiol. 2003 Feb 19;41(4):539-45.

18.
19.

SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes.

Fagerholm E, Ahlqvist E, Forsblom C, Sandholm N, Syreeni A, Parkkonen M, McKnight AJ, Tarnow L, Maxwell AP, Parving HH, Groop L, Groop PH; FinnDiane Study Group.

Diabetologia. 2012 Sep;55(9):2386-93. Epub 2012 May 29.

PMID:
22643932
20.

Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients.

Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I.

J Nephrol. 2005 Nov-Dec;18(6):733-8.

PMID:
16358232
Items per page

Supplemental Content

Write to the Help Desk